3,3'-Carbonylbis(7-methoxy-2H-chromen-2-one)

Catalog No. :
ACGBOY938
CAS No. :
64267-17-0
Molecular Formula :
C21H14O7
Molecular Weight :
378.34

IUPAC Name:3,3'-carbonylbis(7-methoxy-2H-chromen-2-one)

3,3'-Carbonylbis(7-methoxy-2H-chromen-2-one) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$150.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,3'-Carbonylbis(7-methoxy-2H-chromen-2-one)
IUPAC Name3,3'-carbonylbis(7-methoxy-2H-chromen-2-one)
MDL No.MFCD00051377
Molecular FormulaC21H14O7
Molecular Weight378.34
SMILESO=C(C1=CC2=C(OC1=O)C=C(OC)C=C2)C3=CC4=C(OC3=O)C=C(OC)C=C4
InChI KeyKCURVNYQRJVWPY-UHFFFAOYSA-N
Synonym3,3'-Carbonylbis(7-methoxycoumarin),99%;3,3'-CARBONYLBIS(7-METHOXYCOUMARIN);3,3'-Carbonylbis(7-methoxycoumarine);3,3''-CARBONYLBIS(7-METHOXY-2H-1-BENZOPYRAN-2-ONE);2H-1-Benzopyran-2-one, 3,3'-carbonylbis[7-methoxy-;7-methoxy-3-(7-methoxy-2-oxochromene-3-carbonyl)chromen-2-one;3,3'-Carbonylbis(7-methoxy-2H-chromen-2-one)
CAS No.64267-17-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACGBOY938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGBOY938 route product structure diagram
    ACGBOY93864267-17-0 In Stock
Inquiry

2. ACGBOY938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGBOY938 route product structure diagram
    ACGBOY93864267-17-0 In Stock
Inquiry

Comments (0)